Streetbeat News

Stock Prices

DHI

D.R. Horton's (NYSE:DHI) short interest has increased by 21.34% since the last report, with 5.24 million shares sold short, representing 1.99% of its float. This indicates a bearish sentiment among investors, although it's not a definitive predictor of stock movement. The company's short interest is below its peer group average of 5.94%, suggesting less bearish sentiment compared to its peers.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:15 pm

AAPL

AMD

AMZN

GOOG

GOOGL

META

MSFT

NVDA

Apple Inc (AAPL) is nearing a Death Cross on technical charts, indicating a potential downturn. Despite a 10% YTD drop, it's seen as offering more value compared to its Magnificent 7 peers and as part of GOMAAM, which includes Alphabet (GOOG/GOOGL), Meta Platforms (META), Amazon (AMZN), and Microsoft (MSFT). Redditors favor AAPL over NVIDIA (NVDA) and AMD for AI hardware investments.

Portfolio Pulse from Surbhi Jain

March 12, 2024 | 5:07 pm

LHX

MMM

3M Company (NYSE:MMM) shares surged after announcing William M. Bill Brown as the new CEO, effective May 1, 2024. Brown, former CEO of L3Harris Technologies Inc (NYSE:LHX), succeeds Michael Roman, who becomes Executive Chairman. The Board also waived the mandatory retirement age for both Roman and Brown. MMM shares rose 4.41% to $98.20.

Portfolio Pulse from Shivani Kumaresan

March 12, 2024 | 5:05 pm

MSFT

NVDA

ORCL

Oracle Corporation (NYSE:ORCL) experienced a 13% stock value surge following a solid earnings report and a confident outlook, emphasizing 'hypergrowth' in its Gen2 cloud infrastructure business. The company's expansion plans include rapidly opening and expanding cloud datacenters to meet high demand. Analysts have responded positively, with upgrades in ratings and target prices. Oracle's strategic partnerships with Nvidia Corporation (NASDAQ:NVDA) and Microsoft Corporation (NASDAQ:MSFT) further bolster its position in the cloud and AI sectors.

Portfolio Pulse from Neil Dennis

March 12, 2024 | 5:03 pm

QNRX

Quoin Pharmaceuticals (NASDAQ:QNRX) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-2.31. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price following past earnings reports, with the last quarter's beat leading to an 8.26% drop in share price. Currently, shares are trading at $1.14, marking an 81.67% decline over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm

SSSS

SuRo Capital (NASDAQ:SSSS) is expected to report a Q4 earnings per share (EPS) of $-0.14 on March 13, 2024. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions to past earnings reports, with the stock price fluctuating based on actual EPS outcomes and guidance. Shares have been trading at $4.35 as of March 11, with a 52-week increase of 44.85%.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm

NextNav (NASDAQ:NN) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.14. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions to past earnings reports, with share price movements varying significantly post-announcement. Currently, NextNav's shares are trading at $5.26, marking a 150.97% increase over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm

HNRG

Hallador Energy (NASDAQ:HNRG) is scheduled to release its quarterly earnings report on March 13, 2024, with analysts expecting an EPS of $0.29. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting accordingly. Shares have been trading at $7.94 as of March 11, showing a 10.5% increase over the last 52 weeks. Investors are looking for not just an earnings beat but also positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm

SPRO

Spero Therapeutics (NASDAQ:SPRO) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.10. Historical data shows a correlation between earnings performance and stock price movement. Last quarter, SPRO missed its EPS estimate by $0.03, leading to a 1.8% drop in its share price. Over the last year, SPRO shares have increased by 15.99%, indicating a positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm

AADI

Aadi Bioscience (NASDAQ:AADI) is scheduled to release its quarterly earnings report on March 13, 2024, with analysts expecting an EPS of $-0.65. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter beating EPS estimates but resulting in a 3.23% drop in share price the following day. Over the last year, AADI shares have declined by 75.62%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm